Related Experiment Videos
Mitigation of amphotericin B nephrotoxicity by mannitol
British Medical Journal
|March 8, 1975
Summary
This study investigated if mannitol could prevent kidney damage in renal transplant patients treated with amphotericin B for fungal infections. Results suggest mannitol may protect kidney function during this antifungal therapy.
Area of Science:
- Nephrology
- Infectious Diseases
- Pharmacology
Background:
- Renal transplant recipients frequently develop fungal infections.
- Amphotericin B is a common antifungal treatment but often causes nephrotoxicity (kidney damage).
- Azotemia (elevated nitrogenous waste products in blood) is a common side effect of amphotericin B.
Purpose of the Study:
- To evaluate the efficacy of intravenous mannitol in preventing amphotericin B-induced nephrotoxicity in kidney transplant recipients.
- To assess the safety and impact of combined mannitol and amphotericin B therapy on renal function.
Main Methods:
- Four kidney transplant recipients with systemic fungal infections were treated.
- The treatment regimen included intravenous amphotericin B and intravenous mannitol.
- Renal function was monitored throughout the treatment period.
Main Results:
- None of the four patients experienced a significant reduction in renal function.
- A mild metabolic acidosis was observed in some patients.
- Mannitol appeared to mitigate the expected nephrotoxic effects of amphotericin B.
Conclusions:
- Intravenous mannitol may serve as a protective agent against amphotericin B-induced nephrotoxicity in renal transplant recipients.
- This therapeutic approach shows promise for managing fungal infections in this vulnerable patient population without compromising kidney function.
- Further research is warranted to confirm these findings in larger cohorts.